Sharps Technology Inc.

AI Score

0

Unlock

1.97
-0.05 (-2.48%)
At close: Jan 14, 2025, 3:59 PM
1.90
-3.49%
After-hours Jan 14, 2025, 04:08 PM EST
undefined%
Bid 1.98
Market Cap 4.03M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -8.24
PE Ratio (ttm) -0.24
Forward PE n/a
Analyst Buy
Ask 2.13
Volume 14,728
Avg. Volume (20D) 189,241
Open 2.02
Previous Close 2.02
Day's Range 1.94 - 2.02
52-Week Range 1.70 - 18.15
Beta undefined

About STSS

Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York....

Sector Healthcare
IPO Date Apr 14, 2022
Employees 57
Stock Exchange NASDAQ
Ticker Symbol STSS

Analyst Forecast

According to 1 analyst ratings, the average rating for STSS stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.

Buy 100.00%
Hold 0.00%
Sell 0.00%
Stock Forecasts
3 months ago · Source
-26.78%
Sharps Technology shares are trading lower after t... Unlock content with Pro Subscription
6 months ago · Source
-2.67%
Sharps Technology shares are trading higher after the company announced it received two purchase orders for a total of approximately one million SecureGard syringes for 2024 delivery.